Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Genetics

• Publication date

  2013-10-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng.2794PMID 24097065PMCID PMC4051627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts.

  2012cited by this paper
• The DNA dilemma: a test that could change your life.

  2012cited by this paper
• Exome Sequencing and Genetic Testing for MODY

  2012cited by this paper
• Whole-Genome Sequencing: The New Standard of Care?

  2012cited by this paper
• A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes

  2012cited by this paper
• The UCSC Genome Browser database: extensions and updates 2013

  2012cited by this paper
• Taxonomizing, sizing, and overcoming the incidentalome

  2012cited by this paper
• INAUGURAL ARTICLE by a Recently Elected Academy Member:A public resource facilitating clinical use of genomes

  2012cited by this paper
• Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

  2012cited by this paper
• Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes

  2011cited by this paper
• Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants

  2011cited by this paper
• GATA6 haploinsufficiency causes pancreatic agenesis in humans

  2011cited by this paper
• Role of molecular genetics in transforming diagnosis of diabetes mellitus

  2011cited by this paper
• A framework for variation discovery and genotyping using next-generation DNA sequencing data

  2011cited by this paper
• A universal carrier test for the long tail of Mendelian disease.

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

  2010cited by this paper
• A map of human genome variation from population-scale sequencing

  2010cited by this paper
• Genomics, type 2 diabetes, and obesity.

  2010cited by this paper
• Maturity-onset diabetes of the young (MODY): how many cases are we missing?

  2010cited by this paper
• Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

  2010cited by this paper
• Fast and accurate long-read alignment with Burrows–Wheeler transform

  2010cited by this paper
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

  2009cited by this paper
• Update of mutations in the genes encoding the pancreatic beta‐cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism

  2009cited by this paper
• Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing

  2009cited by this paper
• The Human Gene Mutation Database: 2008 update

  2009cited by this paper
• For Young People

  2009cited by this paper
• Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction

  2009cited by this paper
• Lack of pancreatic body and tail in HNF1B mutation carriers

  2008cited by this paper
• Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry

  2008cited by this paper
• The A98V single nucleotide polymorphism (SNP) in hepatic nuclear factor 1 alpha (HNF-1alpha) is associated with insulin sensitivity and beta-cell function.

  2008cited by this paper
• Variation of breast cancer risk among BRCA1/2 carriers.

  2008cited by this paper
• Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes

  2008cited by this paper
• Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young

  2008cited by this paper
• Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study)

  2008cited by this paper
• Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

  2008cited by this paper
• PLINK: a tool set for whole-genome association and population-based linkage analyses.

  2007cited by this paper
• PAX4 mutations in Thais with maturity onset diabetes of the young.

  2007cited by this paper
• From Clinicogenetic Studies of Maturity-Onset Diabetes of the Young to Unraveling Complex Mechanisms of Glucokinase Regulation

  2006cited by this paper
• Principal components analysis corrects for stratification in genome-wide association studies

  2006cited by this paper
• Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction

  2006cited by this paper
• A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry.

  2006cited by this paper
• Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function.

  2005cited by this paper
• Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus

  2005cited by this paper
• Classifying diabetes according to the new WHO clinical stages

  2004cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• 'I don't feel like a diabetic any more': the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing.

  2004cited by this paper
• Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.

  2003cited by this paper
• Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway.

  2003cited by this paper
• Hepatocyte Nuclear Factor-1α Gene Mutations and Diabetes in Norway

  2003cited by this paper
• Confounding, ascertainment bias, and the blind quest for a genetic ‘fountain of youth’

  2003cited by this paper
• No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas.

  2003cited by this paper
• On the use of familial aggregation in population-based case probands for calculating penetrance.

  2002cited by this paper
• The genetic abnormality in the beta cell determines the response to an oral glucose load

  2002cited by this paper
• Type 2 diabetes and obesity.

  2002cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA

  2002cited by this paper
• Large upward bias in estimation of locus-specific effects from genomewide scans.

  2001cited by this paper
• - Cell Genes and Diabetes : Quantitative and Qualitative Differences in the Pathophysiology of Hepatic Nuclear Factor-1 and Glucokinase Mutations

  2001cited by this paper
• Predictive genetic testing in maturity‐onset diabetes of the young (MODY)

  2001cited by this paper
• beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.

  2001cited by this paper
• Pharmacogenetics and the practice of medicine

  2000cited by this paper
• Long‐term outcome of the Malmö Preventive Project: mortality and cardiovascular morbidity

  2000cited by this paper
• GENETICS : AN EXPLOSION OF KNOWLEDGE IS TRANSFORMING CLINICAL PRACTICE

  1999cited by this paper
• Genetics: an explosion of knowledge is transforming clinical practice.

  1999cited by this paper
• Shattuck lecture--medical and societal consequences of the Human Genome Project.

  1999cited by this paper
• Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)

  1999cited by this paper
• A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta.

  1999cited by this paper
• Overview of the Jackson Heart Study: a study of cardiovascular diseases in African American men and women.

  1999cited by this paper
• Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus

  1999cited by this paper
• Liver and Kidney Function in Japanese Patients With Maturity-Onset Diabetes of the Young

  1998cited by this paper
• Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY

  1997cited by this paper
• Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1

  1997cited by this paper
• Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY.

  1997cited by this paper
• Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

  1996cited by this paper
• Human Gene Mutation Database

  1996cited by this paper
• Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects

  1996cited by this paper
• The NEUROD gene maps to human chromosome 2q32 and mouse chromosome 2.

  1996cited by this paper
• Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)

  1996cited by this paper
• Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)

  1996cited by this paper
• Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)

  1996cited by this paper
• Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12

  1996cited by this paper
• Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed?

  1995cited by this paper
• Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver.

  1994cited by this paper
• Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells.

  1993cited by this paper
• Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.

  1993cited by this paper
• Linkage of type 2 diabetes to the glucokinase gene.

  1992cited by this paper
• Cloning of human hepatic nuclear factor 1 (HNF1) and chromosomal localization of its gene in man and mouse.

  1990cited by this paper
• Mapping of the gene TCF2 coding for the transcription factor LFB3 to human chromosome 17 by polymerase chain reaction.

  1990cited by this paper
• An investigation of coronary heart disease in families. The Framingham offspring study.

  1979cited by this paper
• The Framingham study.

  1976cited by this paper
• A Difference Between the Inheritance of Classical Juvenile-onset and Maturity-onset Type Diabetes of Young People

  1975cited by this paper
• Mild familial diabetes with dominant inheritance.

  1974cited by this paper
• Chemistry of insulin; determination of the structure of insulin opens the way to greater understanding of life processes.

  1959cited by this paper
• Epidemiological approaches to heart disease: the Framingham Study.

  1951cited by this paper
• Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor

  year unknowncited by this paper

• Diabetes mellitus HNF4A-MODY in children from the Russian population: clinical and genetic features

  2025cites this paper
• Association of Shared Gene Polymorphisms for Refraction and Axial Length with Corneal Biomechanical Properties in Children.

  2025cites this paper
• Genetic modifiers and ascertainment drive variable expressivity of complex disorders.

  2025cites this paper
• Dissection of type 2 diabetes: a genetic perspective.

  2025cites this paper
• Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects

  2024cites this paper
• Genetic modifiers and ascertainment drive variable expressivity of complex disorders

  2024cites this paper
• A rare homozygous INS variant causes adult-onset diabetes

  2024cites this paper
• Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

  2024cites this paper
• Whole Exome Sequencing in Children With Type 1 Diabetes Before Age 6 Years Reveals Insights Into Disease Heterogeneity

  2024cites this paper
• A Systematic Review of the use of Precision Diagnostics in Monogenic Diabetes

  2023cites this paper
• Monogenic diabetes

  2023cites this paper
• Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: lessons for precision medicine.

  2023cites this paper
• Patients with Type 2 Diabetes and a GCK variant are still at risk for T2D-related secondary complications

  2023cites this paper
• Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteins

  2023cites this paper
• Incomplete penetrance and variable expressivity in monogenic diabetes; a challenge but also an opportunity

  2023cites this paper
• Identification of pathogenic GCK variants in patients with common type 2 diabetes can lead to discontinuation of pharmacological treatment.

  2023cites this paper
• Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients.

  2022cites this paper
• Developmental disorders caused by haploinsufficiency of transcriptional regulators: a perspective based on cell fate determination

  2022cites this paper
• A novel splice-affecting HNF1A variant with large population impact on diabetes in Greenland

  2022cites this paper
• Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts

  2022cites this paper
• Statistical evidence for high‐penetrance MODY‐causing genes in a large population‐based cohort

  2022cites this paper
• A new mutation c.685G>A:p.E229K in the KCNJ11 gene: A case report of maturity-onset diabetes of the young13

  2022cites this paper
• Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts

  2022cites this paper
• Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4

  2022cites this paper
• Search for a time- and cost-saving genetic testing strategy for maturity-onset diabetes of the young

  2022cites this paper
• Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes

  2022cites this paper
• Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of multiple cardiovascular disease risk factors

  2022cites this paper
• HNF1A Mutations and Beta Cell Dysfunction in Diabetes

  2022cites this paper
• Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity Onset Diabetes of the Young.

  2022cites this paper
• Pathogenic variants in actionable MODY genes associate with type 2 diabetes

  2021cites this paper
• First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications

  2021cites this paper
• Gain of function of Malate Dehydrogenase 2 (MDH2) and familial hyperglycemia.

  2021cites this paper
• An intermediate-effect size variant in UMOD confers risk for chronic kidney disease

  2021cites this paper
• Protein Glycosylation in Diabetes.

  2021cites this paper
• NGS Analysis Revealed Digenic Heterozygous GCK and HNF1A Variants in a Child with Mild Hyperglycemia: A Case Report

  2021cites this paper
• The penetrance of age-related monogenic disease depends on ascertainment context

  2021cites this paper
• A Review of Functional Characterization of Single Amino Acid Change Mutations in HNF Transcription Factors in MODY Pathogenesis

  2021cites this paper
• Emerging roles of rare and low-frequency genetic variants in type 1 diabetes mellitus

  2021cites this paper
• Human physiology of genetic defects causing beta-cell dysfunction.

  2020cites this paper
• ‘There and Back Again’—Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension

  2020cites this paper
• Heuristic methods that use random numbers

  2020cites this paper
• How a little logic could have corrected long-held misbeliefs

  2020cites this paper
• Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes.

  2020cites this paper
• Pathogenic variants in actionable MODY genes are associated with type 2 diabetes

  2020cites this paper
• A brief history of human disease genetics

  2020cites this paper
• Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes

  2020cites this paper
• Unsupervised Clustering of Missense Variants in HNF1A Using Multidimensional Functional Data Aids Clinical Interpretation

  2020cites this paper
• Biological behaviors of mutant proinsulin contribute to the phenotypic spectrum of diabetes associated with insulin gene mutations.

  2020cites this paper
• N-glycans as functional effectors of genetic and epigenetic disease risk.

  2020cites this paper
• A machine learning method for selection of genetic variants to increase prediction accuracy of type 2 diabetes mellitus using sequencing data

  2020cites this paper
• HDL cholesterol and apolipoprotein A-I concentrations and risk of atherosclerotic cardiovascular disease: Human genetics to unravel causality.

  2020cites this paper
• Functional analyses of HNF1A-MODY variants refine the interpretation of identified sequence variants.

  2020cites this paper
• How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young

  2019cites this paper
• The Genetic Basis of Metabolic Disease.

  2019cites this paper
• The Contribution of Low-Frequency and Rare Coding Variation to Susceptibility to Type 2 Diabetes

  2019cites this paper
• Diabetes mellitus types: Key genetic determinants and risk assessment

  2019cites this paper
• Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood.

  2019cites this paper
• Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls

  2019cites this paper
• Trapped by Evolution

  2019cites this paper
• Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine

  2019cites this paper
• The Genetic Epidemiology of Type 2 Diabetes: Opportunities for Health Translation

  2019cites this paper
• Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment

  2019cites this paper
• Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes?

  2019cites this paper
• Closing the ‘phenotype gap’ in precision medicine: improving what we measure to understand complex disease mechanisms

  2019cites this paper
• Targeted sequencing identifies novel variants in common and rare MODY genes

  2019cites this paper
• Unsupervised clustering of missense variants in the HNF1A gene using multidimensional functional data aids clinical interpretation

  2019cites this paper
• The Impact of Genetic Variation on Type 2 Diabetes-insights into rare variant susceptibility

  2019cites this paper
• MODY-Diabetes

  2019cites this paper
• Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2019cites this paper
• (2019). Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes. (1), 17-26.

  2019cites this paper
• (2019). Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes. (1), 17-26.

  2019cites this paper
• (2019). Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood. Cell , 177 (3), 587-596.e9.

  2019cites this paper
• Comprehensive genetic screening: The prevalence of maturity‐onset diabetes of the young gene variants in a population‐based childhood diabetes cohort

  2018influential citation
• Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life

  2018cites this paper
• The Common HNF1A Variant I27L Is a Modifier of Age at Diabetes Diagnosis in Individuals With HNF1A-MODY

  2018cites this paper
• Monogenic diabetes in adults: what are the new developments?

  2018cites this paper
• Redefining Disease Causality

  2018cites this paper
• Monogenic disorders of glucose-stimulated insulin secretion: massively parallel sequencing approaches

  2018influential citation
• Genetics: Clues, Not Answers, to the Mysteries of Precision Medicine

  2018cites this paper
• Maturity onset diabetes of the young due to HNF1A variants in Croatia

  2018cites this paper
• Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult–Onset Nonautoimmune Diabetes

  2018cites this paper
• Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

  2018cites this paper
• Novel glucokinase gene mutation in the first Macedonian family tested for MODY.

  2017cites this paper
• Painting a new picture of personalised medicine for diabetes

  2017cites this paper
• University of Southern Denmark High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus

  2017cites this paper
• Genetics of Diabetes: Are They Thrifty Genotype?

  2017cites this paper
• A new comprehensive method for detection of livestock-related pathogenic viruses using a target enrichment system

  2017cites this paper
• Academia–pharma partnerships for novel drug discovery: essential or nice to have?

  2017cites this paper
• The prevalence of DICER1 pathogenic variation in population databases

  2017cites this paper
• Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals

  2017influential citation
• High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus

  2017cites this paper
• The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.

  2017cites this paper
• Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes Prevention

  2017cites this paper
• Evidence-based tailoring of bioinformatics approaches to optimize methods that predict the effects of nonsynonymous amino acid substitutions in glucokinase

  2017cites this paper
• Comprehensive Maturity Onset Diabetes of the Young (MODY) Gene Screening in Pregnant Women with Diabetes in India

  2017cites this paper
• Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry

  2017cites this paper
• Syddansk Universitet High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus

  2017cites this paper
• Human genetics as a model for target validation: finding new therapies for diabetes

  2017cites this paper
• Universitet High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus

  2017cites this paper
• Precision diabetes: learning from monogenic diabetes

  2017cites this paper